

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.15440702 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.15440702 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 9.14517176 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.54509111 |
| 5 | skeletal muscle contraction (GO:0003009) | 8.44751831 |
| 6 | actin-mediated cell contraction (GO:0070252) | 7.51077499 |
| 7 | skeletal muscle adaptation (GO:0043501) | 6.66275080 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.35684858 |
| 9 | skeletal muscle fiber development (GO:0048741) | 5.97718527 |
| 10 | creatine metabolic process (GO:0006600) | 5.86826643 |
| 11 | regulation of cell communication by electrical coupling (GO:0010649) | 5.70092177 |
| 12 | plasma membrane repair (GO:0001778) | 5.62387706 |
| 13 | actin filament-based movement (GO:0030048) | 5.55211006 |
| 14 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.47292128 |
| 15 | NADH metabolic process (GO:0006734) | 5.32949383 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.28783871 |
| 17 | myotube cell development (GO:0014904) | 5.27229053 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.19918455 |
| 19 | striated muscle contraction (GO:0006941) | 5.15353059 |
| 20 | fructose metabolic process (GO:0006000) | 4.97963052 |
| 21 | sarcomere organization (GO:0045214) | 4.91410686 |
| 22 | glycogen catabolic process (GO:0005980) | 4.88743246 |
| 23 | skeletal muscle tissue development (GO:0007519) | 4.88088731 |
| 24 | myofibril assembly (GO:0030239) | 4.68435843 |
| 25 | glucan catabolic process (GO:0009251) | 4.56261969 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 4.50869694 |
| 27 | cardiac muscle hypertrophy (GO:0003300) | 4.38772671 |
| 28 | response to inactivity (GO:0014854) | 4.31045898 |
| 29 | muscle organ morphogenesis (GO:0048644) | 4.29307530 |
| 30 | response to muscle activity (GO:0014850) | 4.28531155 |
| 31 | * muscle contraction (GO:0006936) | 4.22767849 |
| 32 | striated muscle hypertrophy (GO:0014897) | 4.19124211 |
| 33 | gluconeogenesis (GO:0006094) | 4.17773643 |
| 34 | positive regulation of myotube differentiation (GO:0010831) | 4.14635834 |
| 35 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.11949290 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.10869204 |
| 37 | neuromuscular synaptic transmission (GO:0007274) | 4.05837185 |
| 38 | muscle cell fate commitment (GO:0042693) | 3.99406300 |
| 39 | ubiquinone biosynthetic process (GO:0006744) | 3.91228765 |
| 40 | carnitine shuttle (GO:0006853) | 3.89996477 |
| 41 | polysaccharide catabolic process (GO:0000272) | 3.89187361 |
| 42 | muscle fiber development (GO:0048747) | 3.82649227 |
| 43 | * neuronal action potential propagation (GO:0019227) | 3.79335592 |
| 44 | axon ensheathment in central nervous system (GO:0032291) | 3.77976365 |
| 45 | central nervous system myelination (GO:0022010) | 3.77976365 |
| 46 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.77217542 |
| 47 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.75957319 |
| 48 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.75957319 |
| 49 | cellular carbohydrate catabolic process (GO:0044275) | 3.74879245 |
| 50 | * muscle system process (GO:0003012) | 3.74376060 |
| 51 | muscle hypertrophy (GO:0014896) | 3.73880553 |
| 52 | hexose biosynthetic process (GO:0019319) | 3.72686670 |
| 53 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.72656494 |
| 54 | muscle tissue morphogenesis (GO:0060415) | 3.72555454 |
| 55 | myoblast fusion (GO:0007520) | 3.72488433 |
| 56 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.71226418 |
| 57 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.71226418 |
| 58 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.71222662 |
| 59 | striated muscle adaptation (GO:0014888) | 3.70500423 |
| 60 | tricarboxylic acid cycle (GO:0006099) | 3.65208314 |
| 61 | regulation of relaxation of muscle (GO:1901077) | 3.63501977 |
| 62 | negative regulation of protein localization to cell surface (GO:2000009) | 3.63324058 |
| 63 | striated muscle atrophy (GO:0014891) | 3.58956396 |
| 64 | negative regulation of muscle contraction (GO:0045932) | 3.58066130 |
| 65 | skeletal muscle tissue regeneration (GO:0043403) | 3.55708882 |
| 66 | cytidine metabolic process (GO:0046087) | 3.54388642 |
| 67 | cytidine catabolic process (GO:0006216) | 3.54388642 |
| 68 | cytidine deamination (GO:0009972) | 3.54388642 |
| 69 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.53014530 |
| 70 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.52343846 |
| 71 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.51920478 |
| 72 | actomyosin structure organization (GO:0031032) | 3.48988463 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.47902267 |
| 74 | neuromuscular junction development (GO:0007528) | 3.47278182 |
| 75 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.47254039 |
| 76 | regulation of actin filament-based movement (GO:1903115) | 3.45906354 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43125333 |
| 78 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.41936263 |
| 79 | ubiquinone metabolic process (GO:0006743) | 3.41214185 |
| 80 | glycogen biosynthetic process (GO:0005978) | 3.37973056 |
| 81 | glucan biosynthetic process (GO:0009250) | 3.37973056 |
| 82 | cardiac muscle adaptation (GO:0014887) | 3.37178991 |
| 83 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.37178991 |
| 84 | muscle hypertrophy in response to stress (GO:0003299) | 3.37178991 |
| 85 | adult heart development (GO:0007512) | 3.34157803 |
| 86 | regulation of striated muscle contraction (GO:0006942) | 3.33947558 |
| 87 | quinone biosynthetic process (GO:1901663) | 3.33628890 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.33603313 |
| 89 | regulation of coenzyme metabolic process (GO:0051196) | 3.30671328 |
| 90 | regulation of cofactor metabolic process (GO:0051193) | 3.30671328 |
| 91 | oxaloacetate metabolic process (GO:0006107) | 3.30006424 |
| 92 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28889068 |
| 93 | purine nucleotide salvage (GO:0032261) | 3.28882337 |
| 94 | muscle cell cellular homeostasis (GO:0046716) | 3.28625165 |
| 95 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.25869362 |
| 96 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.25587557 |
| 97 | relaxation of muscle (GO:0090075) | 3.25101941 |
| 98 | muscle cell development (GO:0055001) | 3.23739576 |
| 99 | striated muscle tissue development (GO:0014706) | 3.23681171 |
| 100 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.18729866 |
| 101 | respiratory electron transport chain (GO:0022904) | 3.18445868 |
| 102 | muscle atrophy (GO:0014889) | 3.17694621 |
| 103 | heart process (GO:0003015) | 3.16899111 |
| 104 | heart contraction (GO:0060047) | 3.16899111 |
| 105 | cellular polysaccharide metabolic process (GO:0044264) | 3.16783919 |
| 106 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.16117546 |
| 107 | muscle structure development (GO:0061061) | 3.15696173 |
| 108 | cardiac muscle contraction (GO:0060048) | 3.15678482 |
| 109 | membrane depolarization during action potential (GO:0086010) | 3.14477609 |
| 110 | muscle organ development (GO:0007517) | 3.13720646 |
| 111 | substantia nigra development (GO:0021762) | 3.10353764 |
| 112 | fatty acid transmembrane transport (GO:1902001) | 3.08979846 |
| 113 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.08691033 |
| 114 | electron transport chain (GO:0022900) | 3.08186244 |
| 115 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.07232851 |
| 116 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.05290746 |
| 117 | ATP synthesis coupled proton transport (GO:0015986) | 2.98869096 |
| 118 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.98869096 |
| 119 | positive regulation of cation channel activity (GO:2001259) | 2.96828385 |
| 120 | negative regulation of muscle hypertrophy (GO:0014741) | 2.96052755 |
| 121 | regulation of cation channel activity (GO:2001257) | 2.91889013 |
| 122 | muscle adaptation (GO:0043500) | 2.90360261 |
| 123 | cerebellar granule cell differentiation (GO:0021707) | 2.90088255 |
| 124 | neuron cell-cell adhesion (GO:0007158) | 2.89583110 |
| 125 | regulation of membrane repolarization (GO:0060306) | 2.89372282 |
| 126 | glycogen metabolic process (GO:0005977) | 2.87090756 |
| 127 | myotube differentiation (GO:0014902) | 2.84189637 |
| 128 | carnitine transmembrane transport (GO:1902603) | 2.83554868 |
| 129 | striated muscle cell development (GO:0055002) | 2.83244232 |
| 130 | glucan metabolic process (GO:0044042) | 2.80831306 |
| 131 | cellular glucan metabolic process (GO:0006073) | 2.80831306 |
| 132 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.76879008 |
| 133 | calcium ion import (GO:0070509) | 2.76433570 |
| 134 | response to activity (GO:0014823) | 2.76268216 |
| 135 | establishment of mitochondrion localization (GO:0051654) | 2.73945433 |
| 136 | IMP metabolic process (GO:0046040) | 2.73383534 |
| 137 | cardiac myofibril assembly (GO:0055003) | 2.69587718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.56335906 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.92395005 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30549024 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.06164739 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84893245 |
| 6 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.65497826 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.50057261 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46945264 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46586560 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.45580311 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42346511 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34253957 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33460484 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24436360 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19993995 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19993995 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08729065 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07705704 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06564310 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05517131 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04604026 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03644679 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.01648305 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99258576 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96496856 |
| 26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.95807380 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94230611 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89844198 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87437370 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86497877 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.81272402 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79587895 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79497439 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.78726431 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78631456 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72771480 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70670782 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69657527 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68469889 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67719332 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64875209 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63809757 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62610671 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50780806 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49186240 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47704801 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44291797 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43855442 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43004811 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.40971977 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40638159 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40546399 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40162591 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38884740 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.37205953 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36913645 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.35796562 |
| 58 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.35687943 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33847715 |
| 60 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.33237449 |
| 61 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.32661350 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31829263 |
| 63 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.31510518 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30570806 |
| 65 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.30369463 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28613601 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28298648 |
| 68 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.27436612 |
| 69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27329790 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.26190951 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26127622 |
| 72 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.25498019 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23958370 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23319178 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22889202 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22317195 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19402611 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19092490 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18908616 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16841956 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16112473 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15233834 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.13900111 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13699219 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13462394 |
| 86 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.12846458 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12830272 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12688315 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12171900 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11816380 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11430204 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11218132 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10475747 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09561092 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07383892 |
| 96 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06240378 |
| 97 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05720439 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05675267 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05209956 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04452348 |
| 101 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04296792 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03879003 |
| 103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03380792 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02948929 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00860965 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99610622 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99081044 |
| 108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98285337 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98285337 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98258194 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96594306 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96470683 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96009719 |
| 114 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95176694 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94962903 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93392812 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93375490 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93339199 |
| 119 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93290751 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92579064 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92457713 |
| 122 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.91839805 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91236526 |
| 124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90673920 |
| 125 | AR_19668381_ChIP-Seq_PC3_Human | 0.90593031 |
| 126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88401556 |
| 127 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87729675 |
| 128 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87729675 |
| 129 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87721002 |
| 130 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87721002 |
| 131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87410346 |
| 132 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.87219791 |
| 133 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.86985413 |
| 134 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86436893 |
| 135 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85709022 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85551386 |
| 137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85391799 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85058786 |
| 139 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83742242 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83329049 |
| 141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82989485 |
| 142 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82449950 |
| 143 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80019569 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79434368 |
| 145 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79242016 |
| 146 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79230427 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79204121 |
| 148 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78881180 |
| 149 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78843113 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.78776991 |
| 151 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78503398 |
| 152 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78465388 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78322528 |
| 154 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.78033422 |
| 155 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.77991968 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77973231 |
| 157 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.76948653 |
| 158 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.76850095 |
| 159 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76710325 |
| 160 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.76420050 |
| 161 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.75696669 |
| 162 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74614271 |
| 163 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.73585391 |
| 164 | P68_20966046_ChIP-Seq_HELA_Human | 0.72850071 |
| 165 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72628633 |
| 166 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.71592868 |
| 167 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70889859 |
| 168 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70458406 |
| 169 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.70238617 |
| 170 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.69914387 |
| 171 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69494942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004145_abnormal_muscle_electrophysio | 6.35108919 |
| 2 | MP0000749_muscle_degeneration | 5.38971732 |
| 3 | MP0003646_muscle_fatigue | 5.29051647 |
| 4 | MP0000751_myopathy | 5.23980711 |
| 5 | MP0000747_muscle_weakness | 3.88461733 |
| 6 | MP0005451_abnormal_body_composition | 3.85342078 |
| 7 | * MP0002106_abnormal_muscle_physiology | 3.52034483 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.50993773 |
| 9 | * MP0000759_abnormal_skeletal_muscle | 3.21326371 |
| 10 | * MP0004036_abnormal_muscle_relaxation | 3.17573097 |
| 11 | * MP0005369_muscle_phenotype | 2.98841923 |
| 12 | MP0004270_analgesia | 2.91409545 |
| 13 | MP0002269_muscular_atrophy | 2.89446777 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.78406967 |
| 15 | * MP0005620_abnormal_muscle_contractility | 2.71028577 |
| 16 | MP0004130_abnormal_muscle_cell | 2.58479632 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.49074316 |
| 18 | MP0004233_abnormal_muscle_weight | 2.24159249 |
| 19 | MP0003880_abnormal_central_pattern | 2.21524992 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.14658128 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.06919948 |
| 22 | MP0002108_abnormal_muscle_morphology | 1.75100237 |
| 23 | MP0000733_abnormal_muscle_development | 1.73006557 |
| 24 | MP0005330_cardiomyopathy | 1.66203006 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.62683128 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.56152925 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.53196211 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.53013051 |
| 29 | MP0004484_altered_response_of | 1.41832795 |
| 30 | MP0004142_abnormal_muscle_tone | 1.40473064 |
| 31 | MP0009046_muscle_twitch | 1.40302782 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.39582509 |
| 33 | MP0002272_abnormal_nervous_system | 1.37495833 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.36206500 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.34043258 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.33741984 |
| 37 | MP0009745_abnormal_behavioral_response | 1.32284974 |
| 38 | MP0002064_seizures | 1.31227907 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.29725935 |
| 40 | MP0008569_lethality_at_weaning | 1.27903058 |
| 41 | MP0000920_abnormal_myelination | 1.24798108 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.23529619 |
| 43 | MP0004510_myositis | 1.18140514 |
| 44 | MP0004134_abnormal_chest_morphology | 1.13657619 |
| 45 | MP0003137_abnormal_impulse_conducting | 1.13284648 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.12918768 |
| 47 | MP0001486_abnormal_startle_reflex | 1.11394587 |
| 48 | MP0001529_abnormal_vocalization | 1.07770958 |
| 49 | MP0004043_abnormal_pH_regulation | 1.07437654 |
| 50 | * MP0002067_abnormal_sensory_capabilities | 1.07104261 |
| 51 | MP0002971_abnormal_brown_adipose | 1.05346069 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.02950117 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99012468 |
| 54 | MP0001299_abnormal_eye_distance/ | 0.98570723 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 0.96987812 |
| 56 | MP0005666_abnormal_adipose_tissue | 0.96035740 |
| 57 | MP0005670_abnormal_white_adipose | 0.93195444 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 0.92745601 |
| 59 | MP0001905_abnormal_dopamine_level | 0.91722994 |
| 60 | MP0002822_catalepsy | 0.90383058 |
| 61 | MP0000778_abnormal_nervous_system | 0.90156843 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 0.89635362 |
| 63 | MP0005266_abnormal_metabolism | 0.87763292 |
| 64 | MP0005423_abnormal_somatic_nervous | 0.85987992 |
| 65 | MP0004147_increased_porphyrin_level | 0.85552849 |
| 66 | MP0002184_abnormal_innervation | 0.84982884 |
| 67 | MP0003329_amyloid_beta_deposits | 0.84268149 |
| 68 | MP0004924_abnormal_behavior | 0.83810348 |
| 69 | MP0005386_behavior/neurological_phenoty | 0.83810348 |
| 70 | MP0006276_abnormal_autonomic_nervous | 0.83781967 |
| 71 | MP0001661_extended_life_span | 0.82705750 |
| 72 | MP0010630_abnormal_cardiac_muscle | 0.81341772 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.80753888 |
| 74 | MP0000955_abnormal_spinal_cord | 0.80701521 |
| 75 | MP0009250_abnormal_appendicular_skeleto | 0.79945824 |
| 76 | MP0000013_abnormal_adipose_tissue | 0.78176177 |
| 77 | MP0001968_abnormal_touch/_nociception | 0.76713510 |
| 78 | MP0002882_abnormal_neuron_morphology | 0.73024172 |
| 79 | MP0004742_abnormal_vestibular_system | 0.72025961 |
| 80 | MP0003879_abnormal_hair_cell | 0.71278522 |
| 81 | MP0003045_fibrosis | 0.69985216 |
| 82 | MP0000762_abnormal_tongue_morphology | 0.69774068 |
| 83 | MP0004085_abnormal_heartbeat | 0.69735834 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.69577957 |
| 85 | MP0005385_cardiovascular_system_phenoty | 0.69577957 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.65735366 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.64738798 |
| 88 | MP0001970_abnormal_pain_threshold | 0.64212339 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.64067465 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.63143099 |
| 91 | MP0003828_pulmonary_edema | 0.62827789 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.62620627 |
| 93 | * MP0002229_neurodegeneration | 0.62098870 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.59123109 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.58674327 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.58424407 |
| 97 | MP0005083_abnormal_biliary_tract | 0.58287674 |
| 98 | MP0003633_abnormal_nervous_system | 0.58007045 |
| 99 | MP0000266_abnormal_heart_morphology | 0.57949637 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.57600108 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.57034242 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.56361661 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.54852558 |
| 104 | MP0003195_calcinosis | 0.54254102 |
| 105 | MP0001943_abnormal_respiration | 0.53706689 |
| 106 | MP0005166_decreased_susceptibility_to | 0.52982319 |
| 107 | MP0003631_nervous_system_phenotype | 0.52663799 |
| 108 | MP0003634_abnormal_glial_cell | 0.52190320 |
| 109 | MP0006138_congestive_heart_failure | 0.51697591 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.51662804 |
| 111 | MP0003690_abnormal_glial_cell | 0.50836502 |
| 112 | MP0005452_abnormal_adipose_tissue | 0.50201324 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.49349391 |
| 114 | MP0002736_abnormal_nociception_after | 0.48669770 |
| 115 | MP0005535_abnormal_body_temperature | 0.47862646 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46854004 |
| 117 | MP0009672_abnormal_birth_weight | 0.44563202 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.43359895 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.42030046 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.39976434 |
| 121 | MP0005332_abnormal_amino_acid | 0.33369800 |
| 122 | MP0002128_abnormal_blood_circulation | 0.33322477 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.32428474 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.31571373 |
| 125 | MP0005334_abnormal_fat_pad | 0.31354989 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.30550302 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.30345911 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.29617949 |
| 129 | * MP0002114_abnormal_axial_skeleton | 0.28817314 |
| 130 | MP0005165_increased_susceptibility_to | 0.25204042 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.22481209 |
| 132 | MP0010030_abnormal_orbit_morphology | 0.21943277 |
| 133 | MP0002249_abnormal_larynx_morphology | 0.20071579 |
| 134 | MP0000343_altered_response_to | 0.18928015 |
| 135 | MP0003959_abnormal_lean_body | 0.17624951 |
| 136 | MP0003075_altered_response_to | 0.17156661 |
| 137 | MP0002118_abnormal_lipid_homeostasis | 0.16929730 |
| 138 | MP0000249_abnormal_blood_vessel | 0.16282533 |
| 139 | MP0000678_abnormal_parathyroid_gland | 0.15584444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.17284212 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.69864080 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.32244968 |
| 4 | Nemaline bodies (HP:0003798) | 8.24692982 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 7.28781351 |
| 6 | Distal arthrogryposis (HP:0005684) | 6.34856890 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 6.33425248 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 6.31753698 |
| 9 | * Muscle hypertrophy of the lower extremities (HP:0008968) | 6.31753698 |
| 10 | Myopathic facies (HP:0002058) | 5.95976949 |
| 11 | Round ear (HP:0100830) | 5.77298068 |
| 12 | Difficulty running (HP:0009046) | 5.45208890 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.01196263 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 4.86795275 |
| 15 | Myoglobinuria (HP:0002913) | 4.58862037 |
| 16 | Calcaneovalgus deformity (HP:0001848) | 4.50409272 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.49671722 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.40178661 |
| 19 | Absent phalangeal crease (HP:0006109) | 4.27172563 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.19832642 |
| 21 | Deformed tarsal bones (HP:0008119) | 4.04744922 |
| 22 | * Muscle stiffness (HP:0003552) | 4.03591816 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.72312981 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.62957180 |
| 25 | Increased connective tissue (HP:0009025) | 3.51074441 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.50190482 |
| 27 | Neck muscle weakness (HP:0000467) | 3.37828083 |
| 28 | * Myotonia (HP:0002486) | 3.35435766 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.35270820 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.26489530 |
| 31 | Subaortic stenosis (HP:0001682) | 3.26055012 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.26055012 |
| 33 | Shoulder girdle muscle weakness (HP:0003547) | 3.18000860 |
| 34 | Difficulty climbing stairs (HP:0003551) | 2.98599954 |
| 35 | Malignant hyperthermia (HP:0002047) | 2.94446123 |
| 36 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.93504833 |
| 37 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.93504833 |
| 38 | Hyperkalemia (HP:0002153) | 2.91325392 |
| 39 | Sudden death (HP:0001699) | 2.90050382 |
| 40 | Pelvic girdle muscle weakness (HP:0003749) | 2.85937860 |
| 41 | Bundle branch block (HP:0011710) | 2.75293318 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.74864706 |
| 43 | Paralysis (HP:0003470) | 2.65413601 |
| 44 | Focal motor seizures (HP:0011153) | 2.55708706 |
| 45 | Frequent falls (HP:0002359) | 2.50768562 |
| 46 | Nonprogressive disorder (HP:0003680) | 2.39291341 |
| 47 | Abnormality of the calcaneus (HP:0008364) | 2.38929799 |
| 48 | Slender build (HP:0001533) | 2.37433328 |
| 49 | Dilated cardiomyopathy (HP:0001644) | 2.33134038 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.32184593 |
| 51 | Muscular dystrophy (HP:0003560) | 2.30612832 |
| 52 | Fatigable weakness (HP:0003473) | 2.21592098 |
| 53 | Abnormality of the neuromuscular junction (HP:0003398) | 2.21592098 |
| 54 | Ventricular tachycardia (HP:0004756) | 2.20693139 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.20613872 |
| 56 | EMG: neuropathic changes (HP:0003445) | 2.19011355 |
| 57 | Broad-based gait (HP:0002136) | 2.18361060 |
| 58 | Gowers sign (HP:0003391) | 2.16999293 |
| 59 | Limb-girdle muscle weakness (HP:0003325) | 2.16270321 |
| 60 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.11481899 |
| 61 | Hip contracture (HP:0003273) | 2.10970696 |
| 62 | Proximal amyotrophy (HP:0007126) | 2.10546805 |
| 63 | Fetal akinesia sequence (HP:0001989) | 2.09861216 |
| 64 | Hypoplastic ischia (HP:0003175) | 2.06390701 |
| 65 | Bulbar palsy (HP:0001283) | 2.03770981 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 1.96743434 |
| 67 | Lipoatrophy (HP:0100578) | 1.96738556 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 1.96640545 |
| 69 | Scapular winging (HP:0003691) | 1.95975511 |
| 70 | Generalized muscle weakness (HP:0003324) | 1.95225404 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93275035 |
| 72 | Ragged-red muscle fibers (HP:0003200) | 1.91649483 |
| 73 | Atonic seizures (HP:0010819) | 1.89979498 |
| 74 | Achilles tendon contracture (HP:0001771) | 1.89042471 |
| 75 | Heart block (HP:0012722) | 1.88437734 |
| 76 | Stridor (HP:0010307) | 1.86064957 |
| 77 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86046292 |
| 78 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84897702 |
| 79 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84897702 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84369881 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 1.81004859 |
| 82 | Abnormality of the ischium (HP:0003174) | 1.78922720 |
| 83 | Weak cry (HP:0001612) | 1.78729752 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78410280 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 1.75728700 |
| 86 | Exercise intolerance (HP:0003546) | 1.74315532 |
| 87 | Pheochromocytoma (HP:0002666) | 1.73689518 |
| 88 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.73605621 |
| 89 | Lower limb amyotrophy (HP:0007210) | 1.73532072 |
| 90 | Ulnar deviation of finger (HP:0009465) | 1.73235626 |
| 91 | Limb-girdle muscle atrophy (HP:0003797) | 1.73002986 |
| 92 | Progressive muscle weakness (HP:0003323) | 1.71023092 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.70870301 |
| 94 | Long clavicles (HP:0000890) | 1.66553394 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 1.65720965 |
| 96 | Increased muscle lipid content (HP:0009058) | 1.64425822 |
| 97 | Progressive macrocephaly (HP:0004481) | 1.63792864 |
| 98 | Absence seizures (HP:0002121) | 1.62939267 |
| 99 | Popliteal pterygium (HP:0009756) | 1.62546820 |
| 100 | Metatarsus adductus (HP:0001840) | 1.61344491 |
| 101 | Bowel incontinence (HP:0002607) | 1.60898858 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 1.60287228 |
| 103 | Acute encephalopathy (HP:0006846) | 1.60043259 |
| 104 | Urinary urgency (HP:0000012) | 1.59738774 |
| 105 | Spinal rigidity (HP:0003306) | 1.59308102 |
| 106 | Type 2 muscle fiber atrophy (HP:0003554) | 1.58368616 |
| 107 | Waddling gait (HP:0002515) | 1.58104597 |
| 108 | Cholelithiasis (HP:0001081) | 1.56558856 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 1.54910882 |
| 110 | Mitochondrial inheritance (HP:0001427) | 1.54402413 |
| 111 | Ventricular arrhythmia (HP:0004308) | 1.53832625 |
| 112 | Facial diplegia (HP:0001349) | 1.53580715 |
| 113 | Ankle clonus (HP:0011448) | 1.51726011 |
| 114 | Abnormality of the corticospinal tract (HP:0002492) | 1.51452017 |
| 115 | Muscle fiber atrophy (HP:0100295) | 1.48685400 |
| 116 | Amniotic constriction ring (HP:0009775) | 1.42055955 |
| 117 | Abnormality of placental membranes (HP:0011409) | 1.42055955 |
| 118 | Oligomenorrhea (HP:0000876) | 1.35297770 |
| 119 | Limited hip movement (HP:0008800) | 1.33174728 |
| 120 | Abnormality of potassium homeostasis (HP:0011042) | 1.32271798 |
| 121 | Dysmetric saccades (HP:0000641) | 1.29872245 |
| 122 | Cerebral palsy (HP:0100021) | 1.24889565 |
| 123 | Congenital hip dislocation (HP:0001374) | 1.23712946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.51063479 |
| 2 | TTN | 5.24379844 |
| 3 | PHKG2 | 5.16511017 |
| 4 | PHKG1 | 5.16511017 |
| 5 | NME1 | 4.20064787 |
| 6 | PIK3CG | 2.61206429 |
| 7 | STK39 | 2.04792780 |
| 8 | MAP2K4 | 2.04603951 |
| 9 | PINK1 | 2.03449052 |
| 10 | CASK | 1.95149459 |
| 11 | PNCK | 1.91533146 |
| 12 | DMPK | 1.82518513 |
| 13 | MAP3K7 | 1.77442543 |
| 14 | MAPK12 | 1.65216420 |
| 15 | PIK3CA | 1.55696212 |
| 16 | MAP3K4 | 1.55553178 |
| 17 | OXSR1 | 1.54522707 |
| 18 | MAP2K3 | 1.49462783 |
| 19 | MUSK | 1.47361655 |
| 20 | PKN1 | 1.41963642 |
| 21 | EPHB1 | 1.37518224 |
| 22 | PDK3 | 1.36706425 |
| 23 | PDK4 | 1.36706425 |
| 24 | MAPKAPK3 | 1.27927369 |
| 25 | PAK6 | 1.12373548 |
| 26 | BCKDK | 1.10190058 |
| 27 | NTRK3 | 1.08848933 |
| 28 | TNIK | 1.06320740 |
| 29 | CDK19 | 1.05324288 |
| 30 | PRPF4B | 1.04136080 |
| 31 | NEK1 | 1.03245366 |
| 32 | MAPK13 | 1.00844653 |
| 33 | CAMK2G | 0.94689435 |
| 34 | MARK1 | 0.94284161 |
| 35 | PDK2 | 0.93442974 |
| 36 | MAP2K7 | 0.82168442 |
| 37 | MOS | 0.82133365 |
| 38 | MAP2K6 | 0.79443543 |
| 39 | DYRK1B | 0.77742328 |
| 40 | CAMK2B | 0.76242618 |
| 41 | CAMK2D | 0.75915693 |
| 42 | WNK1 | 0.74651306 |
| 43 | EEF2K | 0.74179561 |
| 44 | ROCK2 | 0.74087905 |
| 45 | CCNB1 | 0.73470975 |
| 46 | LIMK1 | 0.73069447 |
| 47 | CAMK2A | 0.71599527 |
| 48 | EPHA4 | 0.70662153 |
| 49 | FGR | 0.70279098 |
| 50 | UHMK1 | 0.66230652 |
| 51 | PRKAA2 | 0.65171641 |
| 52 | MAPKAPK5 | 0.60197128 |
| 53 | TRIB3 | 0.57634073 |
| 54 | PRKAA1 | 0.56213572 |
| 55 | SGK1 | 0.54697541 |
| 56 | KSR2 | 0.53364460 |
| 57 | ICK | 0.53294762 |
| 58 | CAMK4 | 0.52207406 |
| 59 | NTRK1 | 0.51223118 |
| 60 | BCR | 0.51176855 |
| 61 | MAP3K6 | 0.50869504 |
| 62 | CDK5 | 0.50623735 |
| 63 | PRKG1 | 0.50254965 |
| 64 | MAP3K9 | 0.49994783 |
| 65 | WNK4 | 0.49833034 |
| 66 | SGK3 | 0.46442970 |
| 67 | PTK2B | 0.46332274 |
| 68 | GRK7 | 0.44264990 |
| 69 | TBK1 | 0.43326788 |
| 70 | MAP3K13 | 0.43000749 |
| 71 | PAK3 | 0.42273587 |
| 72 | PRKACB | 0.41844878 |
| 73 | MINK1 | 0.41761125 |
| 74 | PLK2 | 0.41747549 |
| 75 | PRKACA | 0.41348080 |
| 76 | TRPM7 | 0.41043274 |
| 77 | MAP2K1 | 0.40905014 |
| 78 | CAMK1G | 0.39884212 |
| 79 | GRK5 | 0.38626632 |
| 80 | RIPK4 | 0.36567453 |
| 81 | RPS6KB2 | 0.35969387 |
| 82 | TLK1 | 0.35604780 |
| 83 | RIPK1 | 0.35428294 |
| 84 | NEK9 | 0.35346911 |
| 85 | RPS6KA3 | 0.35273319 |
| 86 | TIE1 | 0.35230464 |
| 87 | PRKD1 | 0.34194377 |
| 88 | PDPK1 | 0.33950932 |
| 89 | CDK14 | 0.33793143 |
| 90 | SGK223 | 0.32697473 |
| 91 | SGK494 | 0.32697473 |
| 92 | SGK2 | 0.31702701 |
| 93 | AKT2 | 0.31267995 |
| 94 | KSR1 | 0.30768294 |
| 95 | STK11 | 0.30392095 |
| 96 | TAOK2 | 0.29572869 |
| 97 | ILK | 0.29046092 |
| 98 | CDK15 | 0.28021288 |
| 99 | TYRO3 | 0.27699306 |
| 100 | RPS6KB1 | 0.27426434 |
| 101 | PRKCG | 0.27262268 |
| 102 | NTRK2 | 0.26821601 |
| 103 | ROCK1 | 0.25688728 |
| 104 | TNK2 | 0.25499090 |
| 105 | CDK18 | 0.25416121 |
| 106 | KIT | 0.24943635 |
| 107 | MAP3K11 | 0.24559210 |
| 108 | MAP3K12 | 0.24117932 |
| 109 | PRKCQ | 0.23685190 |
| 110 | RPS6KL1 | 0.23640633 |
| 111 | RPS6KC1 | 0.23640633 |
| 112 | DAPK2 | 0.23097412 |
| 113 | RPS6KA1 | 0.22892754 |
| 114 | ERBB3 | 0.22353261 |
| 115 | CDK11A | 0.22120014 |
| 116 | SIK1 | 0.22025598 |
| 117 | MAPK11 | 0.21972062 |
| 118 | MAPK7 | 0.21663083 |
| 119 | RPS6KA6 | 0.21477726 |
| 120 | MAP3K1 | 0.21147354 |
| 121 | MAPK10 | 0.21017159 |
| 122 | ZAP70 | 0.20954200 |
| 123 | FES | 0.20719611 |
| 124 | LATS2 | 0.20623242 |
| 125 | PDK1 | 0.19556849 |
| 126 | CSNK1G2 | 0.18805685 |
| 127 | MAPK4 | 0.17790295 |
| 128 | CAMK1 | 0.17731372 |
| 129 | PRKACG | 0.13584676 |
| 130 | ABL2 | 0.11249693 |
| 131 | IRAK1 | 0.10321176 |
| 132 | MARK3 | 0.10072883 |
| 133 | TAOK1 | 0.09973662 |
| 134 | RPS6KA2 | 0.08230581 |
| 135 | MAP2K2 | 0.07985666 |
| 136 | MAP3K3 | 0.07621634 |
| 137 | MTOR | 0.05754901 |
| 138 | PAK1 | 0.03971368 |
| 139 | MAPK3 | 0.03825414 |
| 140 | CSNK1D | 0.03082682 |
| 141 | PRKG2 | 0.02929379 |
| 142 | MARK2 | 0.02694014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.78549381 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.08517374 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.04455208 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.79393676 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.70888012 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.69264685 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.67871796 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38302903 |
| 9 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.35711057 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.20012433 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15976086 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.03459764 |
| 13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.02481489 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87212204 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.79465652 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.72331886 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.66149518 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64360238 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62561628 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61279544 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57383288 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55678732 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.54437965 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53775119 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51471911 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51251686 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.50466337 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49429475 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.49241093 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.45262025 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.41662758 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.37654161 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35972069 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34957813 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.33264396 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31442417 |
| 37 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29074566 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.28269114 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26933273 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26353182 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.21765150 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21100499 |
| 43 | Tight junction_Homo sapiens_hsa04530 | 1.16997596 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14531738 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12532330 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.12039651 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02386358 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.00276072 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99637684 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98012420 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97800909 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96543109 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95248926 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92378426 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.91713332 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89720692 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88134813 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88043537 |
| 59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87431162 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.86513479 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.84457342 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83118033 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80730836 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80380843 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77777781 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.76394389 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72371441 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70998510 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69685818 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69181480 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68770950 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67799062 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66224789 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65547526 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65446874 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64260718 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.64135569 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63998336 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61924417 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61303352 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.59282830 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59243152 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56158117 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54138776 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52829323 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51768807 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51313459 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49993504 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49639733 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47843842 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.47459824 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46724018 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46514792 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.46063992 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44447039 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43678265 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43624843 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43502957 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41704305 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41436557 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40500361 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38937932 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38486109 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38276273 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38098905 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36546441 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35910055 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35662719 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35112851 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34659743 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33356966 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31620550 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31434031 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31187570 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30939861 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30551345 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30092785 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.29783342 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27640086 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25917893 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.20841049 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20542740 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19816577 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.17358920 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15821924 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14289520 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.13772897 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13218334 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.11150240 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10409129 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.09871181 |
| 132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.05732910 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.02496278 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.00436126 |

